Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price objective lifted by Royal Bank of Canada from $11.00 to $14.00 in a research report released on Tuesday morning, Marketbeat reports. The brokerage currently has an outperform rating on the stock. Separately, Needham & Company LLC upgraded shares of Verrica Pharmaceuticals from a hold rating to […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) Director Paul B. Manning bought 200,000 shares of Verrica Pharmaceuticals stock in a transaction on Monday, July 24th. The stock was acquired at an average cost of $5.02 per share, for a total transaction of $1,004,000.00. Following the acquisition, the director now owns 7,851,128 shares in the […]
BML Capital Management LLC acquired a new position in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,110,605 shares of the company’s stock, valued at approximately $3,054,000. Verrica Pharmaceuticals accounts for approximately 2.9% of BML Capital Management […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Rating) – Analysts at Brookline Capital Management lowered their Q2 2023 earnings estimates for shares of Verrica Pharmaceuticals in a report released on Tuesday, May 9th. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings per share of ($0.28) for the quarter, down from […]